We are live on ! Find out more
BLC

Brown, Lisle/Cummings Portfolio holdings

AUM $400M
1-Year Est. Return 18.79%
This Fund
S&P 500
This Quarter Est. Return
+5.82%
1 Year Est. Return
+18.79%
3 Year Est. Return
+61.76%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$224M
AUM Growth
+$26.5M
Cap. Flow
+$16.5M
Cap. Flow %
7.39%
Top 10 Hldgs %
27.71%
Holding
558
New
25
Increased
144
Reduced
58
Closed
2

Top Buys

Rank Stock Value
1
CNI icon
Canadian National Railway
CNI
+$1.38M
2
JPM icon
JPMorgan Chase
JPM
+$932K
3
TROW icon
T. Rowe Price
TROW
+$814K
4
JNJ icon
Johnson & Johnson
JNJ
+$659K
5
SCHW
Charles Schwab
SCHW
+$636K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$256K
2
BUD icon
AB InBev
BUD
+$191K
3
GE icon
GE Aerospace
GE
+$138K
4
GILD icon
Gilead Sciences
GILD
+$108K
5
INTC icon
Intel
INTC
+$72.9K

Sector Composition

Rank Sector Weight
1 Healthcare 17.74%
2 Technology 16.33%
3 Financials 12.83%
4 Industrials 8.85%
5 Communication Services 6.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FVD icon
426
First Trust Value Line Dividend Fund
FVD
$8.33B
$9.02K ﹤0.01%
225
– –
RF icon
427
Regions Financial
RF
$26.9B
$8.91K ﹤0.01%
500
– –
VLO icon
428
Valero Energy
VLO
$88.5B
$8.8K ﹤0.01%
75
– –
GNTX icon
429
Gentex
GNTX
$4.99B
$8.78K ﹤0.01%
300
– –
MKC icon
430
McCormick & Company Non-Voting
MKC
$13.9B
$8.72K ﹤0.01%
100
– –
TPR icon
431
Tapestry
TPR
$31.4B
$8.56K ﹤0.01%
200
– –
ARKG icon
432
ARK Genomic Revolution ETF
ARKG
$1.6B
$8.52K ﹤0.01%
250
– –
CIEN icon
433
Ciena
CIEN
$55.3B
$8.5K ﹤0.01%
200
– –
ICVX
434
DELISTED
Icosavax, Inc. Common Stock
ICVX
$8.44K ﹤0.01%
850
– –
BKLN icon
435
Invesco Senior Loan ETF
BKLN
$6.78B
$8.42K ﹤0.01%
400
– –
HDV
436
iShares Core High Dividend ETF
HDV
$14.8B
$8.37K ﹤0.01%
415
– –
EFG icon
437
iShares MSCI EAFE Growth ETF
EFG
$16.7B
$8.3K ﹤0.01%
87
– –
OXY icon
438
Occidental Petroleum
OXY
$55.2B
$8.23K ﹤0.01%
140
– –
DTM icon
439
DT Midstream
DTM
$13.8B
$8.23K ﹤0.01%
+166
New +$7.94K
CRI icon
440
Carter's
CRI
$1.47B
$7.99K ﹤0.01%
110
– –
DCI icon
441
Donaldson
DCI
$11.1B
$7.81K ﹤0.01%
125
– –
PHM icon
442
Pultegroup
PHM
$24.6B
$7.77K ﹤0.01%
100
– –
DNP icon
443
DNP Select Income Fund
DNP
$4.06B
$7.73K ﹤0.01%
738
– –
TTD icon
444
Trade Desk
TTD
$8.6B
$7.72K ﹤0.01%
100
– –
FSV icon
445
FirstService
FSV
$6.61B
$7.71K ﹤0.01%
50
– –
MUB icon
446
iShares National Muni Bond ETF
MUB
$45.2B
$7.68K ﹤0.01%
+72
New +$7.7K
GOGL
447
DELISTED
Golden Ocean Group
GOGL
$7.55K ﹤0.01%
1,000
– –
NDAQ icon
448
Nasdaq
NDAQ
$52.6B
$7.48K ﹤0.01%
+150
New +$8.13K
MCHP icon
449
Microchip Technology
MCHP
$40.8B
$7.44K ﹤0.01%
83
– –
SRE icon
450
Sempra
SRE
$57.3B
$7.28K ﹤0.01%
100
– –
16 17
18
19 20

Similar funds

JGCM
Joseph Group Capital Management Columbus, Ohio $400M AUM 18.42% 1-Year Est. Return
AIM
Alpine Investment Management Hong Kong $401M AUM 17.09% 1-Year Est. Return
SFCL
Strengthening Families & Communities LLC Boston, Massachusetts $401M AUM 33.17% 1-Year Est. Return
TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return
DBIA
Dumont & Blake Investment Advisors Princeton, New Jersey $400M AUM 21.87% 1-Year Est. Return
KHCM
Kettle Hill Capital Management New York $399M AUM 10.05% 1-Year Est. Return
MM
Meridian Management Little Rock, Arkansas $402M AUM 17.05% 1-Year Est. Return
IAA
Ironsides Asset Advisors Rocky Mount, North Carolina $399M AUM 13.99% 1-Year Est. Return

Brown, Lisle/Cummings's Q2 2023 Portfolio in Review

As of Q2 2023, Brown, Lisle/Cummings held 558 positions worth $224M, up 13% from $197M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Brown, Lisle/Cummings deployed $16.5M of net new capital in Q2 2023, opening 25 new positions and adding to 144 existing holdings. Its largest new stake was Charles Schwab: 12,150 shares worth $689K.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $256K trimmed.

  • Brown, Lisle/Cummings's largest Q2 2023 buy was Charles Schwab: 12,150 shares worth $689K.
  • Brown, Lisle/Cummings added most to Canadian National Railway in Q2 2023, an estimated $1.38M increase.
  • Brown, Lisle/Cummings's biggest Q2 2023 reduction was Bristol-Myers Squibb, cutting an estimated $256K.
  • Brown, Lisle/Cummings fully exited J.M. Smucker in Q2 2023, selling an estimated $15.7K.
  • Brown, Lisle/Cummings's ten largest holdings make up 28% of its $224M portfolio in Q2 2023.
  • Brown, Lisle/Cummings opened 25 new positions and closed 2 in Q2 2023.
  • Brown, Lisle/Cummings's portfolio value rose 13% quarter-over-quarter to $224M.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2023, filed 1 Jul 2024.